Delivery Order SPE2DR25D3301-SPE2DR26F18SV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Scemblix 40 mg tablets (60-count unit doses) with a ceiling value of $13,259.50. This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Scemblix 40 mg tablets (60-count units) valued at $27,946.94 with a firm fixed-price arrangement. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Scemblix 40 mg tablets in quantities of 60 units, with a ceiling value of $31,912.66 and a completion date of January 26, 2026. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,259.50 on November 6, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for December 1, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $39,778.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Scemblix 40 mg tablets (60-count units). The contract, which is not set-aside and was competitively awarded, is scheduled for completion by October 16, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) under a firm fixed-price contract. The order, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,973.47 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of December 30, 2025, and an award date of December 8, 2025. The pharmaceutical product will be delivered to the company's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $15,935.65 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 28, 2026, for the supply of Scemblix 20 mg tablets in quantities of 60 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of February 19, 2026. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,519.00 for 60 tablets of Scemblix 40 mg by the Defense Logistics Agency's Medical Supply Chain on August 6, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The ultimate completion date is set for August 27, 2025, with performance to occur...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for $13,973.47 to supply Scemblix 40 mg tablets (60-count units) with a completion date of December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as the vendor's...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18SVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Scemblix (40 mg tablets) in quantities of 60s, with a ceiling value of $13,973.47 and an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime vendor under the DLA's pharmaceutical supply chain, the company maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Scemblix, a specialized pharmaceutical product, exemplifies the company's role in fulfilling federal healthcare requirements through competitive procurement and demonstrates its capability to meet both routine and specialized medication supply needs for Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 11/27/25 |